Literature DB >> 8040254

Cell type-specific gene expression in the neuroendocrine system. A neuroendocrine-specific regulatory element in the promoter of chromogranin A, a ubiquitous secretory granule core protein.

H Wu1, D J Rozansky, N J Webster, D T O'Connor.   

Abstract

The acidic secretory protein chromogranin A universally occurs in amine and peptide hormone and neurotransmitter storage granules throughout the neuroendocrine system. What factors govern the activity of the chromogranin A gene, to yield such a widespread yet neuroendocrine-selective pattern of expression? To address this question, we isolated the mouse chromogranin A gene promoter. The promoter conferred cell type-specific expression in several neuroendocrine cell types (adrenal medullary chromaffin cells, anterior pituitary corticotropes, and anterior pituitary somatolactotropes) but not in control (fibroblast or kidney) cells. In neuroendocrine cells, analysis of promoter deletions established both positive and negative transcriptional regulatory domains. A distal positive domain (-4.8/-2.2 kbp) was discovered, as well as negative (-258/-181 bp) and positive (-147/-61 bp) domains in the proximate promoter. The proximate promoter contained a minimal neuroendocrine-specific element between -77 and -61 bp. Sequence alignment of the mouse promoter with corresponding regions in rat and bovine clones indicated that the mouse sequence shares over 85% homology with rat and 52% with bovine promoters. DNaseI footprinting and electrophoretic gel mobility shift assays demonstrated the presence of nuclear factors in neuroendocrine cells that recognized the proximate promoter. We conclude that the chromogranin A promoter contains both positive and negative domains governing its cell type-specific pattern of transcription, and that a small proximate region of the promoter, containing novel as well as previously described elements, interacts specifically with neuroendocrine nuclear proteins, and is thereby sufficient to ensure widespread neuroendocrine expression of the gene.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8040254      PMCID: PMC296289          DOI: 10.1172/JCI117297

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  73 in total

1.  High efficiency vectors for cosmid microcloning and genomic analysis.

Authors:  G A Evans; K Lewis; B E Rothenberg
Journal:  Gene       Date:  1989-06-30       Impact factor: 3.688

Review 2.  Evolutionary conservation of elements in the upstream glucokinase promoter.

Authors:  M A Magnuson; T L Jetton
Journal:  Biochem Soc Trans       Date:  1993-02       Impact factor: 5.407

Review 3.  Storage and release of neurotransmitters.

Authors:  R B Kelly
Journal:  Cell       Date:  1993-01       Impact factor: 41.582

4.  Regulation of expression of dopamine beta-hydroxylase in PC12 cells by glucocorticoids and cyclic AMP analogues.

Authors:  A McMahon; E L Sabban
Journal:  J Neurochem       Date:  1992-12       Impact factor: 5.372

5.  Identification of a gonadotropin-releasing hormone-responsive region in the glycoprotein hormone alpha-subunit promoter.

Authors:  T W Kay; J L Jameson
Journal:  Mol Endocrinol       Date:  1992-11

6.  Enhanced effectiveness of pulsatile 3',5'-cyclic adenosine monophosphate in stimulating prolactin and alpha-subunit gene expression.

Authors:  D J Haisenleder; M Yasin; J C Marshall
Journal:  Endocrinology       Date:  1992-12       Impact factor: 4.736

7.  Pur-1, a zinc-finger protein that binds to purine-rich sequences, transactivates an insulin promoter in heterologous cells.

Authors:  G C Kennedy; W J Rutter
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

8.  Identification of the functional regulatory region of the neurotrophin-3 gene promoter.

Authors:  A Shintani; Y Ono; Y Kaisho; R Sasada; K Igarashi
Journal:  Brain Res Mol Brain Res       Date:  1993-01

9.  The organisation of the mouse secretogranin II gene.

Authors:  A Schimmel; O Bräunling; U Rüther; W B Huttner; H H Gerdes
Journal:  FEBS Lett       Date:  1992-12-21       Impact factor: 4.124

10.  Identification and characterization of a 3',5'-cyclic adenosine monophosphate-responsive element in the human corticotropin-releasing hormone gene promoter.

Authors:  D Spengler; R Rupprecht; L P Van; F Holsboer
Journal:  Mol Endocrinol       Date:  1992-11
View more
  10 in total

1.  Stimulus coupling to transcription versus secretion in pheochromocytoma cells. Convergent and divergent signal transduction pathways and the crucial roles for route of cytosolic calcium entry and protein kinase C.

Authors:  K Tang; H Wu; S K Mahata; M Mahata; B M Gill; R J Parmer; D T O'Connor
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

2.  Chromogranin A transcription and gene expression in Folliculostellate (TtT/GF) cells inhibit cell growth.

Authors:  Gail A Stilling; Jill M Bayliss; Long Jin; Heyu Zhang; Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

3.  Peptidergic activation of transcription and secretion in chromaffin cells. Cis and trans signaling determinants of pituitary adenylyl cyclase-activating polypeptide (PACAP).

Authors:  L Taupenot; S K Mahata; H Wu; D T O'Connor
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

4.  Genetic variation within a metabolic motif in the chromogranin a promoter: pleiotropic influence on cardiometabolic risk traits in twins.

Authors:  Fangwen Rao; Stephane Chiron; Zhiyun Wei; Maple M Fung; Yuqing Chen; Gen Wen; Srikrishna Khandrika; Michael G Ziegler; Beben Benyamin; Grant Montgomery; John B Whitfield; Nicholas G Martin; Jill Waalen; Bruce A Hamilton; Sushil K Mahata; Daniel T O'Connor
Journal:  Am J Hypertens       Date:  2011-09-15       Impact factor: 2.689

5.  Pancreastatin secretion by pituitary adenomas and regulation of chromogranin B mRNA expression.

Authors:  L Jin; B W Scheithauer; W F Young; D H Davis; G G Klee; R V Lloyd
Journal:  Am J Pathol       Date:  1996-06       Impact factor: 4.307

6.  A functional cyclic AMP response element plays a crucial role in neuroendocrine cell type-specific expression of the secretory granule protein chromogranin A.

Authors:  H Wu; S K Mahata; M Mahata; N J Webster; R J Parmer; D T O'Connor
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

7.  Common genetic variants in the chromogranin A promoter alter autonomic activity and blood pressure.

Authors:  Y Chen; F Rao; J L Rodriguez-Flores; N R Mahapatra; M Mahata; G Wen; R M Salem; P-A B Shih; M Das; N J Schork; M G Ziegler; B A Hamilton; S K Mahata; D T O'Connor
Journal:  Kidney Int       Date:  2008-04-23       Impact factor: 10.612

8.  Both rare and common polymorphisms contribute functional variation at CHGA, a regulator of catecholamine physiology.

Authors:  Gen Wen; Sushil K Mahata; Peter Cadman; Manjula Mahata; Sajalendu Ghosh; Nitish R Mahapatra; Fangwen Rao; Mats Stridsberg; Douglas W Smith; Payam Mahboubi; Nicholas J Schork; Daniel T O'Connor; Bruce A Hamilton
Journal:  Am J Hum Genet       Date:  2004-01-12       Impact factor: 11.025

9.  An ancestral variant of Secretogranin II confers regulation by PHOX2 transcription factors and association with hypertension.

Authors:  Gen Wen; Jennifer Wessel; Weidong Zhou; Georg B Ehret; Fangwen Rao; Mats Stridsberg; Sushil K Mahata; Peter M Gent; Madhusudan Das; Richard S Cooper; Aravinda Chakravarti; Huilin Zhou; Nicholas J Schork; Daniel T O'connor; Bruce A Hamilton
Journal:  Hum Mol Genet       Date:  2007-06-21       Impact factor: 6.150

10.  Analysis of the chromogranin A post-translational cleavage product pancreastatin and the prohormone convertases PC2 and PC3 in normal and neoplastic human pituitaries.

Authors:  R V Lloyd; L Jin; X Qian; B W Scheithauer; W F Young; D H Davis
Journal:  Am J Pathol       Date:  1995-05       Impact factor: 4.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.